Effects of oral diltiazem on platelet function: alone and in combination with "low dose" aspirin

Michael E. Ring, James J. Corrigan, Paul E Fenster

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The effects of 3 days of oral diltiazem, "low dose" aspirin (40 mg/day), and their combination on platelet function was studied in 5 normal subjects. Both drugs inhibited platelet aggregation and ATP release induced by collagen, epinephrine and threshold concentrations of ADP. Aspirin and diltiazem decreased thromboxane A2 generation during ADP induced aggregation by 94 percent and 53 percent respectively, however both agents inhibited aggregation similarly, which suggests that diltiazem's anti-platelet effect was due to mechanisms other than inhibition of thromboxane metabolism alone. Combination therapy resulted in a partially additive inhibitory effect on ADP induced aggregation and thromboxane A2 generation. Two subjects had bleeding times over 15 minutes after receiving combination therapy.

Original languageEnglish (US)
Pages (from-to)391-400
Number of pages10
JournalThrombosis Research
Volume44
Issue number3
DOIs
StatePublished - Nov 1 1986

Fingerprint

Diltiazem
Adenosine Diphosphate
Aspirin
Thromboxane A2
Blood Platelets
Bleeding Time
Thromboxanes
Platelet Aggregation
Epinephrine
Collagen
Adenosine Triphosphate
Therapeutics
Pharmaceutical Preparations

Keywords

  • aspirin
  • Diltiazem
  • platelet aggregation
  • thromboxane

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Hematology

Cite this

Effects of oral diltiazem on platelet function : alone and in combination with "low dose" aspirin. / Ring, Michael E.; Corrigan, James J.; Fenster, Paul E.

In: Thrombosis Research, Vol. 44, No. 3, 01.11.1986, p. 391-400.

Research output: Contribution to journalArticle

@article{94cbf8c8db254a1591e97df79db2a779,
title = "Effects of oral diltiazem on platelet function: alone and in combination with {"}low dose{"} aspirin",
abstract = "The effects of 3 days of oral diltiazem, {"}low dose{"} aspirin (40 mg/day), and their combination on platelet function was studied in 5 normal subjects. Both drugs inhibited platelet aggregation and ATP release induced by collagen, epinephrine and threshold concentrations of ADP. Aspirin and diltiazem decreased thromboxane A2 generation during ADP induced aggregation by 94 percent and 53 percent respectively, however both agents inhibited aggregation similarly, which suggests that diltiazem's anti-platelet effect was due to mechanisms other than inhibition of thromboxane metabolism alone. Combination therapy resulted in a partially additive inhibitory effect on ADP induced aggregation and thromboxane A2 generation. Two subjects had bleeding times over 15 minutes after receiving combination therapy.",
keywords = "aspirin, Diltiazem, platelet aggregation, thromboxane",
author = "Ring, {Michael E.} and Corrigan, {James J.} and Fenster, {Paul E}",
year = "1986",
month = "11",
day = "1",
doi = "10.1016/0049-3848(86)90013-7",
language = "English (US)",
volume = "44",
pages = "391--400",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Effects of oral diltiazem on platelet function

T2 - alone and in combination with "low dose" aspirin

AU - Ring, Michael E.

AU - Corrigan, James J.

AU - Fenster, Paul E

PY - 1986/11/1

Y1 - 1986/11/1

N2 - The effects of 3 days of oral diltiazem, "low dose" aspirin (40 mg/day), and their combination on platelet function was studied in 5 normal subjects. Both drugs inhibited platelet aggregation and ATP release induced by collagen, epinephrine and threshold concentrations of ADP. Aspirin and diltiazem decreased thromboxane A2 generation during ADP induced aggregation by 94 percent and 53 percent respectively, however both agents inhibited aggregation similarly, which suggests that diltiazem's anti-platelet effect was due to mechanisms other than inhibition of thromboxane metabolism alone. Combination therapy resulted in a partially additive inhibitory effect on ADP induced aggregation and thromboxane A2 generation. Two subjects had bleeding times over 15 minutes after receiving combination therapy.

AB - The effects of 3 days of oral diltiazem, "low dose" aspirin (40 mg/day), and their combination on platelet function was studied in 5 normal subjects. Both drugs inhibited platelet aggregation and ATP release induced by collagen, epinephrine and threshold concentrations of ADP. Aspirin and diltiazem decreased thromboxane A2 generation during ADP induced aggregation by 94 percent and 53 percent respectively, however both agents inhibited aggregation similarly, which suggests that diltiazem's anti-platelet effect was due to mechanisms other than inhibition of thromboxane metabolism alone. Combination therapy resulted in a partially additive inhibitory effect on ADP induced aggregation and thromboxane A2 generation. Two subjects had bleeding times over 15 minutes after receiving combination therapy.

KW - aspirin

KW - Diltiazem

KW - platelet aggregation

KW - thromboxane

UR - http://www.scopus.com/inward/record.url?scp=0022819583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022819583&partnerID=8YFLogxK

U2 - 10.1016/0049-3848(86)90013-7

DO - 10.1016/0049-3848(86)90013-7

M3 - Article

C2 - 3798404

AN - SCOPUS:0022819583

VL - 44

SP - 391

EP - 400

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 3

ER -